Medeon Biodesign (ROCO:6499) Cyclically Adjusted Book per Share: NT$29.28 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6499 Medeon Biodesign Inc ROCO:6499
73 GF Score
Price NT$75.30
GF Value NT$96.64
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medeon Biodesign Cyclically Adjusted Book per Share?

Medeon Biodesign ROCO:6499 +9.93% 73 Cyclically Adjusted Book per Share is NT$29.28 as of Jun. 2026. GuruFocus rates ROCO:6499 with a GF Score™ of 73/100 and a GF Value™ of NT$96.64 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Medeon Biodesign's adjusted book value per share for the three months ended in Jun. 2026 was NT$12.685. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$29.28 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Medeon Biodesign's average Cyclically Adjusted Book Growth Rate was 1.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-30), Medeon Biodesign's current stock price is NT$75.30. Medeon Biodesign's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was NT$29.28. Medeon Biodesign's Cyclically Adjusted PB Ratio of today is 2.57.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Medeon Biodesign was 4.70. The lowest was 1.30. And the median was 1.78.


Medeon Biodesign  (ROCO:6499) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Medeon Biodesign's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=75.30/29.28
=2.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Medeon Biodesign was 4.70. The lowest was 1.30. And the median was 1.78.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Medeon Biodesign Cyclically Adjusted Book per Share Related Terms


Medeon Biodesign Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Medeon Biodesign's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medeon Biodesign Cyclically Adjusted Book per Share Chart

Medeon Biodesign Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 26.60 28.82 28.56

Medeon Biodesign Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.89 28.68 28.56 29.03 29.28

ROCO:6499 vs ISRG, BDX, MDLN: Cyclically Adjusted Book per Share Comparison

For the Medical Instruments & Supplies subindustry, Medeon Biodesign's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medeon Biodesign Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medeon Biodesign's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Medeon Biodesign's Cyclically Adjusted PB Ratio falls into.


ROCO:6499
73GF Score
Medeon Biodesign Inc ROCO:6499
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medeon Biodesign Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medeon Biodesign's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=12.685/333.9520*333.9520
=12.685

Current CPI (Jun. 2026) = 333.9520.

Medeon Biodesign Quarterly Data

Book Value per Share CPI Adj_Book
201609 21.099 241.428 29.185
201612 20.124 241.432 27.836
201703 19.353 243.801 26.509
201706 18.599 244.955 25.356
201709 17.793 246.819 24.074
201712 16.763 246.524 22.708
201803 21.371 249.554 28.599
201806 21.147 251.989 28.025
201809 20.533 252.439 27.163
201812 20.422 251.233 27.146
201903 24.207 254.202 31.801
201906 22.864 256.143 29.809
201909 22.062 256.759 28.695
201912 21.534 256.974 27.985
202003 20.973 258.115 27.135
202006 20.247 257.797 26.228
202009 19.208 260.280 24.645
202012 22.101 260.474 28.336
202103 22.051 264.877 27.801
202106 48.333 271.696 59.408
202109 45.669 274.310 55.599
202112 44.448 278.802 53.240
202203 44.669 287.504 51.886
202206 41.837 296.311 47.152
202209 40.800 296.808 45.906
202212 38.713 296.797 43.559
202303 36.489 301.836 40.372
202306 29.244 305.109 32.009
202309 27.346 307.789 29.670
202312 24.960 306.746 27.174
202403 22.928 312.332 24.515
202406 20.693 314.175 21.996
202409 18.482 315.301 19.575
202412 16.337 315.605 17.287
202503 14.438 319.799 15.077
202506 11.850 322.561 12.268
202509 12.596 324.800 12.951
202512 15.222 324.054 15.687
202603 14.010 330.213 14.169
202606 12.685 333.952 12.685

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$29.28 mean?
Medeon Biodesign (ROCO:6499) has a Cyclically Adjusted Book per Share of NT$29.28 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Medeon Biodesign and its competitors.
Is Medeon Biodesign's Cyclically Adjusted Book per Share too high?
Medeon Biodesign's current Cyclically Adjusted Book per Share is NT$29.28. Overall, Medeon Biodesign has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medeon Biodesign's Cyclically Adjusted Book per Share compare to ISRG and BDX?
Medeon Biodesign's Cyclically Adjusted Book per Share of NT$29.28 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Medeon Biodesign and its competitors. Medeon Biodesign's current Cyclically Adjusted Book per Share is NT$29.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medeon Biodesign stock overvalued right now?
Based on GuruFocus' analysis, Medeon Biodesign (ROCO:6499) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$96.64, compared to a current price of NT$75.30 — trading 22.1% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$29.28. Medeon Biodesign's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Medeon Biodesign (ROCO:6499), the current Cyclically Adjusted Book per Share is NT$29.28 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medeon Biodesign (ROCO:6499) Overvalued in 2026?

Based on GuruFocus' analysis, Medeon Biodesign stock appears to be undervalued. The current stock price of NT$75.30 is trading 22.1% below its estimated GF Value™ of NT$96.64. GuruFocus considers Medeon Biodesign to be Modestly Undervalued.

Key valuation signals for ROCO:6499:

  • Cyclically Adjusted Book per Share: NT$29.28
  • GF Value™: NT$96.64 vs. price of NT$75.30 (22.1% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the ROCO:6499 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medeon Biodesign Business Description

Address No. 116, HouGang Street, 7th Floor, Shilin District, Taipei, TWN, 11170
Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.
73GF Score

Get the complete analysis for ROCO:6499

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$75.30
Price
NT$96.64
GF Value